Risk-adapted multimodal laboratory cervical screening -- application of new technologies to cervical cancer prevention
- PMID: 15861512
Risk-adapted multimodal laboratory cervical screening -- application of new technologies to cervical cancer prevention
Abstract
The objective of screening for cervical cancer is to reduce the mortality and incidence of the disease. To date, there is extensive and strong evidence that this can be achieved by cytology-based screening programs, which continue to be the mainstay of cervical prevention worldwide despite their inherent methodological limitations. This article presents a review on the utility of conventional, ancillary, and experimental methods for cervical screening both as single tests and test-combinations, and describes possible future directions for enhanced screening accuracy using risk-adapted protocols.
Similar articles
-
[Risk-adapted multimodal laboratory cervical screening---Pap test of the future?].Pathologe. 2007 Sep;28(5):334-8. doi: 10.1007/s00292-007-0923-9. Pathologe. 2007. PMID: 17661045 German.
-
[Integrating HPV testing for primary screening?].J Gynecol Obstet Biol Reprod (Paris). 2008 Feb;37 Suppl 1:S139-51. doi: 10.1016/j.jgyn.2007.11.020. Epub 2008 Jan 8. J Gynecol Obstet Biol Reprod (Paris). 2008. PMID: 18191912 Review. French.
-
Cervical cancer screening in the early post vaccine era.Obstet Gynecol Clin North Am. 2008 Dec;35(4):537-48; vii. doi: 10.1016/j.ogc.2008.09.005. Obstet Gynecol Clin North Am. 2008. PMID: 19061815 Review.
-
Cervical cancer screening programs in Latin America and the Caribbean.Vaccine. 2008 Aug 19;26 Suppl 11:L37-48. doi: 10.1016/j.vaccine.2008.06.013. Vaccine. 2008. PMID: 18945401 Review.
-
The current and future role of screening in the era of HPV vaccination.Gynecol Oncol. 2008 May;109(2 Suppl):S31-9. doi: 10.1016/j.ygyno.2008.02.001. Gynecol Oncol. 2008. PMID: 18482556 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical